IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
about
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemiaCD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Diagnosis and subclassification of acute lymphoblastic leukemiaAntigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomabCharacterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia.Children's Oncology Group's 2013 blueprint for research: acute lymphoblastic leukemia.Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biology.A case of pediatric B-Lymphoblastic leukemia presenting with a t(9;12)(p24;q11.2) involving JAK2 and concomitant MLL rearrangement with apparent insertion at 6q27Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia.Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target.Eradication of B-ALL using chimeric antigen receptor-expressing T cells targeting the TSLPR oncoprotein.Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.Genomic Copy Number Variations in the Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients with del(5q) and/or -7/del(7q).A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.The clinical characteristics, therapy and outcome of 85 adults with acute lymphoblastic leukemia and t(4;11)(q21;q23)/MLL-AFF1 prospectively treated in the UKALLXII/ECOG2993 trial.Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.Interleukin 7 and thymic stromal lymphopoietin: from immunity to leukemia.The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia.Adolescent and young adult patients with cancer: a milieu of unique features.Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia.Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients.A population-based single nucleotide polymorphism array analysis of genomic aberrations in younger adult acute lymphoblastic leukemia patients.Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.Overexpression of lymphoid enhancer-binding factor-1 (LEF1) is a novel favorable prognostic factor in childhood acute lymphoblastic leukemia.Loss-of-function but not dominant-negative intragenic IKZF1 deletions are associated with an adverse prognosis in adult BCR-ABL-negative acute lymphoblastic leukemia.Philadelphia chromosome-like acute lymphoblastic leukemia.Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization are complementary techniques to detect cytogenetic abnormalities in multiple myeloma.Suppressors and activators of JAK-STAT signaling at diagnosis and relapse of acute lymphoblastic leukemia in Down syndrome.The role of G protein-coupled receptors in lymphoid malignancies.Diagnostic evaluation of RNA sequencing for the detection of genetic abnormalities associated with Ph-like acute lymphoblastic leukemia (ALL).High frequency of IKZF1 genetic alterations in adult patients with B-cell acute lymphoblastic leukemia.Prognostic significance of IKZF1 deletion in adult B cell acute lymphoblastic leukemia: a meta-analysis.Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia.Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.Acute lymphoblastic leukaemiaAcute lymphoblastic leukemia
P2860
Q26749177-3BA47A0F-FA17-4EEB-A697-B9BA131F2584Q26783433-5C62CCC5-22BD-4406-8EB8-888C81D9F67FQ26824387-26836814-FED7-4973-8091-1F900A72916DQ27013710-9749B5C7-429F-4485-B6E7-36354129B9A7Q33578333-F9B0128B-F20D-4273-8341-2131D21B631FQ33711119-36CA00AF-14B2-46B2-B47A-95E2B6AC4CA7Q34016431-311FF699-678F-4D0F-8AE2-2F6578C95C2DQ34256192-83909A02-AECE-4169-A4BC-DB9D94BBE35CQ34749600-F01D412A-A009-4340-B3F7-52B53AE20A20Q34798023-48771554-EA1B-4903-9508-604D5E70E894Q35572318-25C8C075-7054-4A5E-B5D4-82DC5D59D6D9Q35904943-5BE34AE2-EC80-45DE-B5AD-A7BAF9B09007Q35922398-A15D7503-AA13-4AD4-9D88-4D1207329A50Q36064278-7291C088-5F52-4C93-ADFD-DFA5B4314E3CQ36640716-FDEE6DE0-92A2-415E-94D2-60716681A488Q36892609-5ACDF656-068B-4D18-8E69-F0CE3A66B5B5Q36967133-5CBEB7C3-492B-49A7-B6A0-70EB1066AE9FQ38102578-55C3B8BC-2BAC-43B2-BD5E-C17C0A37F13AQ38460308-7836E9E1-58D0-4C59-8E91-056F7BB3D7E0Q38502885-8EC13211-2882-469C-9709-1F4B9AE7315FQ38813978-83817ED2-23A3-456A-A250-629756D77185Q38841153-C49BD8CA-D9F1-4FC0-A8EE-6103D526526DQ41366254-C16567A8-2BA1-4B58-8D14-3DD127C8488CQ41697696-9B3DC27C-5BCB-4D54-A99B-60724757C849Q41752588-43C0643A-D477-4A50-804F-B996779EDD67Q42368324-F7381542-2F1E-4F2E-B274-047F78CA5901Q43431904-A82835AE-A5C6-4B88-B88D-3D86BA6E4C2CQ44092678-347DDCAB-14B6-4802-8C59-9AB46C89AED1Q45233800-454C0923-0BF3-46BB-8E4E-2733FB97401EQ47960121-C0E3DD23-22D3-49A8-9A05-6588C01CD868Q50547293-66E0CC2F-E2AF-4019-80F5-DDCD57693849Q50921558-932A8EBE-F7BE-4E3D-BC7B-EB9B2EF343F8Q51343198-7B9167A9-1383-481E-8C59-C4D8F06E7F6FQ53765766-32770F13-5C74-458D-BDDF-12657AB8A1A7Q53831155-4581B40A-1150-4E3E-9320-CE825D3A3170Q58481753-626E34B3-7579-4B6D-8265-F0F0C79BDE86Q58481759-BFEDBBE8-8F5A-4E7D-BC43-93BACE019F91
P2860
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
IGH@ translocations, CRLF2 der ...... acute lymphoblastic leukemia.
@en
IGH@ translocations, CRLF2 der ...... acute lymphoblastic leukemia.
@nl
type
label
IGH@ translocations, CRLF2 der ...... acute lymphoblastic leukemia.
@en
IGH@ translocations, CRLF2 der ...... acute lymphoblastic leukemia.
@nl
prefLabel
IGH@ translocations, CRLF2 der ...... acute lymphoblastic leukemia.
@en
IGH@ translocations, CRLF2 der ...... acute lymphoblastic leukemia.
@nl
P2093
P356
P1476
IGH@ translocations, CRLF2 der ...... acute lymphoblastic leukemia.
@en
P2093
Adele K Fielding
Anthony H Goldstone
Anthony V Moorman
Bella Patel
Claire Schwab
Dino Masic
Hannah M Ensor
Heather Morrison
Jacob M Rowe
Lisa J Russell
P304
P356
10.1200/JCO.2011.40.3907
P407
P577
2012-07-30T00:00:00Z